Alkermes to present at J.P. Morgan Healthcare Conference; highlights profitability and neuroscience focus

Alkermes plc.

Presentation on Jan 10, 2024, titled 'Profitable, Pure-play Neuroscience Company'.
CEO Richard Pops to present at the 42nd Annual J.P. Morgan Healthcare Conference.
No specific financial or operational data disclosed in the excerpt provided.

item 7.01 item 9.01

Alkermes plc. filing history →

Source: SEC EDGAR

accession 0000950170-24-002678

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.